How do you choose which LHRH agonist or antagonist to prescribe for ADT in patients with prostate cancer?   

What clinical considerations factor into your decision to choose leuprolide vs goserelin vs triptorelin vs degarelix, etc?



Answer from: Medical Oncologist at Academic Institution